Evidence map›Paper›PMID 40459828›Full record

ArticleDoklady. Biochemistry and biophysics2025

Evidence for Functionality of Transmembrane Domains of Predicted Non-Canonical Plant Phosphotransmitters.

S N Lomin, E M Savelieva, A S Elanskaya, D V Arkhipov, G A Romanov

Abstract read
PubMed Publisher
In one paragraph

Article in Doklady. Biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. An Unusual Component of the Multistep Phosphorelay from Tea Plant (International journal of molecular sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S N LominTimiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia.
E M SavelievaTimiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia. savelievaek@ya.ru.
A S ElanskayaTimiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia.
D V ArkhipovTimiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia.
G A RomanovTimiryazev Institute of Plant Physiology, Russian Academy of Sciences, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioinformatic methods have been used to predict a new subclass of proteins among plant phosphotransmitters involved in the signaling system of multistep phosphorelay. In contrast to the canonical soluble nucleocytosolic forms, the found noncanonical phosphotransmitter sequences, belonging to a wide range of plant taxa, potentially contain transmembrane domains. This suggests localization of such proteins on cell membranes and, therefore, a different function in signaling than that of canonical phosphotransmitters. We tested the functionality of the transmembrane domain of the phosphotransmitter using the protein of the tea plant Camellia sinensis. The membrane localization of the transiently expressed recombinant phosphotransmitter with this domain was confirmed by microscopy and immunoblotting. Thus, this is the first study to obtain experimental evidence for the existence of membrane-bound plant phosphotransmitters with as yet unknown functions. These data suggest the presence of a noncanonical membrane branch of signal transduction in the multistep phosphorelay system in plants.

Indexed as

Camellia sinensisCell MembraneMembrane ProteinsPlant ProteinsAmino Acid SequenceProtein DomainsSignal TransductionMembrane ProteinsPlant Proteinscytokininsphosphotransmittersplantsrecombinant proteinssignal transductiontransmembrane domain

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.